VAERS reports by lot

GSK Varicella/Shingles lot 34EC5: VAERS reports

31 VAERS reports list lot 34EC5 as a GSK Varicella/Shingles vaccine, received between 2023-03-09 and 2024-06-17. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
31
Reports
6%
Marked serious
0
With a death outcome
7
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)1919%
Dermatological (non-injection-site)1818%
Injection-site / Local reaction1818%
Musculoskeletal1212%
Neurological1111%
Cardiac / Cardiovascular77%
Allergic / Anaphylactic77%
Gastrointestinal44%
Respiratory33%
Psychiatric / Neuropsychiatric11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Florida6
North Carolina3
Texas3
New York2
Illinois2
Tennessee2
California1
Mississippi1
Kentucky1
Colorado1
Nevada1
Oregon1

Reports by month received

2023-039
2023-049
2023-055
2023-065
2023-071
2023-081
2024-061

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.